Rehumanizing global health care with agentic AI

The framing here is notably political as much as technical: positioning AI agents as a corrective to decades of deliberate underinvestment in global health infrastructure shifts the accountability question from 'can the technology work?' to 'who decides where it gets deployed and on whose terms?'. That governance gap goes unaddressed in the piece.

This lands directly on top of the argument Hugging Face made on June 1st in 'Beyond LLMs: Why Scalable Enterprise AI Adoption Depends on Agent Logic,' which positioned agentic architectures as the necessary next layer once LLM pilots stall. The MIT Technology Review piece is essentially a domain-specific proof of that thesis, applied to a sector where coordination failures are measurable and the stakes for reliability are higher than in typical enterprise deployments. The Iteris coverage from arXiv the same day adds a useful counterpoint: agentic loops work well in constrained, evaluable problem spaces, and healthcare delivery is considerably messier than computational mathematics. Sutton's warning about generative systems lacking built-in evaluation mechanisms is also worth holding here, since autonomous health agents making resource allocation decisions need exactly the feedback architecture he argues most current systems lack.

Watch whether any of the health system pilots cited in the piece publish outcome data with defined error-rate thresholds within 18 months. Deployment claims without pre-registered success criteria in a clinical context should be treated as marketing until audited results appear.